Watching Lantern Pharma; Zacks Small Cap Research Gives Stock $26 Price Valuation
Portfolio Pulse from Benzinga Newsdesk
Zacks Small Cap Research has given Lantern Pharma (LTRN) a price valuation of $26. This valuation reflects a positive outlook for the company's stock.
August 12, 2024 | 2:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Zacks Small Cap Research has given Lantern Pharma (LTRN) a price valuation of $26, reflecting a positive outlook for the company's stock.
The $26 price valuation from Zacks Small Cap Research suggests a positive sentiment towards Lantern Pharma's stock, which is likely to boost investor confidence and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100